Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

Brodalumab (Amgen), secukinumab (Novartis) and ixekizumab (Eli Lilly) all work by interfering with the IL-17 pathway. Secukinumab and ixekizumab target IL-17, while brodalumab targets a specific receptor that binds to the IL-17 cytokine.

https://www.psoriasis.org/advance/features/interleukin-17-could-unlock-psoriasis-treatments

Good luck and GOD bless,

George